Ambrisentan 10mg tablets
NHS hospitals in England used £25,866,253 of indicative cost of Ambrisentan 10mg tablets in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 12.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ambrisentan 10mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ambrisentan 10mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Sheffield Teaching Hospitals Nhs Trust | £10,184,025 |
| Imperial College Healthcare Nhs Trust | £3,661,836 |
| Guy's & St Thomas' Nhs Foundation Trust | £3,659,358 |
| Royal Papworth Hospital Nhs Ft | £3,152,033 |
| Royal Free London Nhs Foundation Trust | £2,394,123 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,804,706 |
| Manchester University Nhs Ft | £487,044 |
| Hull And East Yorkshire Hpls Nhs Trust | £311,644 |
| Maidstone And Tunbridge Wells Nhs Trust | £9,709 |
| Leeds Teaching Hpls Nhs Trust | £8,090 |
The primary-care picture
Ambrisentan is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ambrisentan medicine page.